Literature DB >> 1858943

Hepatic portal infusion of glucagon antibodies increases spontaneous meal size in rats.

J Le Sauter1, U Noh, N Geary.   

Abstract

Specific antibodies to pancreatic glucagon in a dose sufficient to neutralize 1.5 ng glucagon in vitro were intraportally infused during the first 2 min of spontaneous meals in ad libitum-fed male Sprague-Dawley rats. In separate tests, glucagon antibodies stimulated feeding during the first spontaneous meal of the dark phase (73% mean increase in meal size) and during spontaneous meals in the last quarter of the dark phase (58% increase). These results indicate that a glucagon-sensitive satiety mechanism has a physiological role in the control of nocturnal feeding in rats.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1858943     DOI: 10.1152/ajpregu.1991.261.1.R162

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

Review 1.  Central control of body weight and appetite.

Authors:  Stephen C Woods; David A D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2008-11       Impact factor: 5.958

Review 2.  Pancreatic signals controlling food intake; insulin, glucagon and amylin.

Authors:  Stephen C Woods; Thomas A Lutz; Nori Geary; Wolfgang Langhans
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

Review 3.  Intestinal feedback signaling and satiety.

Authors:  Timothy H Moran; Megan J Dailey
Journal:  Physiol Behav       Date:  2011-02-17

Review 4.  Physiologic and Neural Controls of Eating.

Authors:  Timothy H Moran; Ellen E Ladenheim
Journal:  Gastroenterol Clin North Am       Date:  2016-10-13       Impact factor: 3.806

5.  Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus.

Authors:  P B Jensen; N Blume; J D Mikkelsen; P J Larsen; H I Jensen; J J Holst; O D Madsen
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

Review 6.  The metabolic actions of glucagon revisited.

Authors:  Kirk M Habegger; Kristy M Heppner; Nori Geary; Timothy J Bartness; Richard DiMarchi; Matthias H Tschöp
Journal:  Nat Rev Endocrinol       Date:  2010-10-19       Impact factor: 43.330

7.  Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis.

Authors:  N Blume; J Skouv; L I Larsson; J J Holst; O D Madsen
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 8.  The incretin/glucagon system as a target for pharmacotherapy of obesity.

Authors:  Stefano Del Prato; Baptist Gallwitz; Jens Juul Holst; Juris J Meier
Journal:  Obes Rev       Date:  2021-10-28       Impact factor: 10.867

9.  Glucagon's Metabolic Action in Health and Disease.

Authors:  Anja Zeigerer; Revathi Sekar; Maximilian Kleinert; Shelly Nason; Kirk M Habegger; Timo D Müller
Journal:  Compr Physiol       Date:  2021-04-01       Impact factor: 9.090

10.  Effect of Dietary Macronutrients on Postprandial Glucagon and Insulin Release in Obese and Normal-Weight Women.

Authors:  Tomasz Wikarek; Piotr Kocełak; Aleksander J Owczarek; Jerzy Chudek; Magdalena Olszanecka-Glinianowicz
Journal:  Int J Endocrinol       Date:  2020-04-30       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.